Advisor Group Holdings, Inc. Navidea Biopharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.72 - $1.2 $1,548 - $2,580	-2,150 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$1.53 - $1.85 $3,060 - $3,700	2,000 Added 1333.33%	2,150 $4,000
Q1 2021 May 13, 2021	BUY	$1.99 - $2.9 $286 - $417	144 Added 2400.0%	150 $0
Q4 2020 Feb 10, 2021	SELL	$1.88 - $2.84 $564 - $852	-300 Reduced 98.04%	6 $0
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $210 - $1,248	300 Added 5000.0%	306 $1,000
Q1 2020 May 18, 2020	BUY	$0.76 - $1.54 $4 - $9	6 New	6 $0

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.